tiprankstipranks
Holding GB:CURE?
Track your performance easily

GB:CURE Technical Analysis

Summary of all the Indicators

Summary
Sell
6Bullish
2Neutral
14Bearish
Oscillators
Buy
6Bullish
2Neutral
2Bearish
Moving Averages
Strong Sell
0Bullish
0Neutral
12Bearish
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) Moving Averages Convergence Divergence (MACD) indicator is -0.05, suggesting VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD is a Buy.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 20-Day exponential moving average is 19.89, making it a Sell.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 50-Day exponential moving average is 19.83, making it a Sell.

VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD (CURE) Pivot Points

Dec 22, 2024, 10:14 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
18.85
18.85
18.85
18.85
18.85
18.85
18.85
Fibonacci
18.85
18.85
18.85
18.85
18.85
18.85
18.85

VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD (CURE) Moving Averages

Dec 22, 2024, 10:14 AM
Period
Simple
Exponential
MA5
19.59Sell
19.52Sell
MA10
20.02Sell
19.79Sell
MA20
20.12Sell
19.89Sell
MA50
19.78Sell
19.83Sell
MA100
19.68Sell
19.73Sell
MA200
19.46Sell
19.57Sell
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 10-Day exponential moving average is 19.79, making it a Sell.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 100-Day exponential moving average is 19.73, making it a Sell.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 50-day simple moving average is 19.78, creating a Sell signal.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 100-day simple moving average is 19.68, creating a Sell signal.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 200-day simple moving average is 19.46, creating a Sell signal.

VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD (CURE) Technical Analysis

Dec 22, 2024, 10:14 AM
Name
Value
Action
RSI (14)
40.35
Neutral
STOCH (9,6)
13.94
Buy
STOCHRSI (14)
13.26
Buy
MACD (12,26)
-0.05
Buy
ADX (14)
19.67
Buy
Williams %R
-77.37
Buy
CCI (14)
-191.83
Buy
ATR (14)
0.23
-
Ultimate Oscillator
40.03
Neutral
ROC
-4.93
Sell
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) Relative Strength Index (RSI) is 40.35, creating a Neutral signal.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) Trend Strength Indicator (ADX) is 19.67, creating a Buy signal.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) Commodity Channel Index (CCI) is -191.83, creating a Buy signal.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) Price Rate of Change (ROC) is -4.93, creating a Sell signal.

FAQ

Is CURE a Buy, Hold, or Sell?
Based on CURE’s technical indicators, CURE is a Sell.
    What is CURE’s RSI (14)?
    CURE’s RSI (14) is 40.35, which suggests CURE is a Neutral.
      What is CURE’s MACD?
      CURE’s MACD is -0.05, which suggests CURE is a Buy.
        What is CURE’s 5-day moving average?
        CURE’s 5-day moving average is 19.59, which suggests CURE is a Sell.
          What is CURE’s 20-day moving average?
          CURE 20-day moving average is 20.12, which suggests CURE is a Sell.
            What is CURE’s 50-day moving average?
            CURE’s 50-day moving average is 19.78, which suggests CURE is a Sell.
              What is CURE’s 200-day moving average?
              CURE’s 200-day moving average is 19.46, which suggests CURE is a Sell.
                What is CURE’s Williams % R (14)?
                CURE’s Williams % R (14) is -77.37, which suggests CURE is a Buy.
                  What is CURE’s CCI (14)?
                  CURE’s CCI (14) is -191.83, which suggests CURE is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis